Healthcare Industry News: ACL reconstruction
News Release - June 13, 2007
Cayenne Medical Expands Executive StaffCFO and VP, Marketing Among Additions to Management Team, as Company Readies Commercial Launch of AperFix(TM) Technology
SCOTTSDALE, Ariz.--(HSMN NewsFeed)--Cayenne Medical, Inc., a privately held sports medicine company based in Scottsdale, announced that it has named Daniel P. Murray as Chief Financial Officer and Timothy S. Nash to the post of Vice President, Marketing.
Murray joins Cayenne after serving as the Corporate Controller for St. Francis Medical Technologies, Inc. With over twenty years of senior business management experience in a broad range of early stage and large corporate environments, Murray was instrumental in the $725M acquisition of St. Francis by Kyphon Inc. earlier this year. He has also held senior financial management positions with Azul Systems, Inc., Dell Inc, Tandem Computers, Inc. and PriceWaterhouseCoopers.
Nash brings to Cayenne more than sixteen years of sales and marketing experience in the sports medicine, orthopedic and spinal industries. Immediately prior to his arrival at Cayenne, Nash served as National Sales Manager for Medtronic Spine and Biologics, where, among his achievements was the creation and oversight the company's neuromonitoring sales force. Prior to Medtronic, Nash was Global Product Manager of Arthroscopy for Zimmer Orthopedics.
The announcement of the new CFO and VP Marketing hires comes on the heels of Cayenne closing a $12.7 million Series B equity financing round and FDA market clearance for the company's platform AperFix(TM) System for ACL reconstruction. AperFix enables surgeons to perform a revolutionary, five-minute surgical procedure resulting in total repair of the ACL. Cayenne has now completed its limited market release and will be commercially launching the AperFix system domestically within the next 30-60 days.
"We're proud to continue adding richly experienced executives such as Dan and Tim to our senior executive team at Cayenne Medical," said James W. Hart, Cayenne's President and CEO. "In terms of marketing and financial know-how, Tim and Dan, respectively, are the right match for us at this crucial time in our development."
"We have assembled a first rate team here at Cayenne," added Hart. "Ideally positioning us for our next big step as an organization - the nationwide commercial launch of our platform ACL technology, AperFix."
The AperFix System, in a revolutionary, five-minute surgical procedure, provides active aperture compression and fixation with strong, rigid femoral and tibial implants made of polyetheretherketone (PEEK(TM)). Cayenne's inserter handles facilitate rapid delivery of strong, rigid implants while simultaneously tensioning the graft to reduce laxity. For surgeons, AperFix provides a complete yet simple solution for consistent, replicable results utilizing the hamstring and other soft tissue grafts.
About Cayenne Medical, Inc.:
Based in Scottsdale, Arizona, Cayenne Medical is a privately held medical device company defining new technology for the soft tissue reconstruction segment of the sports medicine market. The company was founded in 2005 and is focused on leading the transformation of traditional ACL repair procedures by applying advanced technology through minimally invasive techniques. For more information, go to www.cayennemedical.com
Source: Cayenne Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.